Standout Papers

Emerging pharmaceutical t... 2016 2026 2019 2022 2020 2016 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Emerging pharmaceutical therapies for osteoarthritis
    2020 287 citations Augustin Latourte, M. Kloppenburg et al. Nature Reviews Rheumatology profile →
  2. Systemic inhibition of IL-6/Stat3 signalling protects against experimental osteoarthritis
    2016 275 citations Augustin Latourte, C. Cherifi et al. Annals of the Rheumatic Diseases profile →

Immediate Impact

1 from Science/Nature 54 hit
Sub-graph 1 of 21

Citing Papers

Osteoarthritis
2025 Hit
Conducting Hydrogel‐Based Neural Biointerfacing Technologies
2025 Hit
1 intermediate paper

Works of Augustin Latourte being referenced

Emerging pharmaceutical therapies for osteoarthritis
2020 Hit

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Augustin Latourte 719 352 272 227 210 51 1.2k
M. Uchida 447 0.6× 302 0.9× 172 0.6× 109 0.5× 272 1.3× 23 1.1k
Yue Yang 378 0.5× 465 1.3× 141 0.5× 151 0.7× 83 0.4× 47 1.1k
Seong Jae Choi 547 0.8× 276 0.8× 132 0.5× 160 0.7× 91 0.4× 33 1.2k
A Lussier 457 0.6× 262 0.7× 164 0.6× 258 1.1× 275 1.3× 53 1.2k
Sung Won Lee 334 0.5× 421 1.2× 111 0.4× 101 0.4× 80 0.4× 65 1.1k
Raghunatha R. Yammani 526 0.7× 627 1.8× 59 0.2× 189 0.8× 82 0.4× 35 1.3k
Masayuki Hosoi 162 0.2× 472 1.3× 239 0.9× 92 0.4× 180 0.9× 42 1.4k
Levinus B. A. van de Putte 1.0k 1.4× 164 0.5× 62 0.2× 105 0.5× 159 0.8× 37 1.4k
Won Tae Chung 471 0.7× 246 0.7× 125 0.5× 80 0.4× 58 0.3× 59 911
Jun Yuan 210 0.3× 292 0.8× 232 0.9× 45 0.2× 140 0.7× 52 1.2k

All Works

Loading papers...

Rankless by CCL
2026